IL1B and acute respiratory distress syndrome: ALI mouse model showed synergistic effects between buformin (an AMPK pathway activator) and p65 siRNA (which silences p65 mRNA expression), leading to a significant reduction in the inflammatory cytokines IL‐1β and IL‐18.